期刊文献+

胸腺嘧啶核苷磷酸化酶与子宫内膜癌关系的研究

A study on thymidine phosphorylase in endometrial carcinoma
下载PDF
导出
摘要 目的 :探讨胸腺嘧啶核苷磷酸化酶 (TP)与子宫内膜癌的临床病理特征、无瘤生存率、微血管密度 (MVD)的关系。方法 :采用免疫组织化学方法检测 40例子宫内膜癌蜡块组织中的TP的表达水平及MVD。结果 :TP阳性肿瘤的MVD明显高于TP阴性肿瘤。病理分级G1的TP阳性率明显高于G2 、G3 ,肌层未受累或侵犯肌层≤ 1/ 2的TP阳性率明显高于侵犯肌层 >1/ 2者 ,手术分期Ⅰ期、Ⅱ期总的TP阳性率明显高于Ⅲ期。结论 :TP具有促血管增生作用 。 To study the relationships between the expression of thymidine phosphorylase (TP),the density of microvessels(MVD)of the tumor,the clinical and pathological features and tumor free survival rate in endometrial carcinoma.Methods:The expression of TP and the intratumor MVD were determined by immunohistochemistry.Results:Of the 40 tumors,24(60%) were TP positive.MVD was significantly higher in TP positive tumors than that in TP negative tumors.TP positive rate was significantly higher in those cases that myometrium invasion without invasion or with invasion not exceeding 1/2 than that in those cases with invasion exceeding 1/2;in those cases of G 1 grade than that in those cases of G 2 and G 3,and in those cases of stages Ⅰ and Ⅱ than that in those cases of stage Ⅲ.There was no significant correlations between TP and menopausal status,estrogen receptor,progesterone receptor,lymph node metastasis and tumor free survival rate.Conclusion:TP played an important role in angiogenesis,especially in the early stage or well differentiated endometrial carcinoma.
出处 《中日友好医院学报》 2001年第1期7-10,共4页 Journal of China-Japan Friendship Hospital
关键词 子宫内膜癌 胸腺嘧啶核苷磷酸化酶 微血管密度 血管增生 endometrial carcinoma thymidine phosphorylase density of microvessels angiogenesis
  • 相关文献

参考文献9

  • 1[1]Matsushita S,Nitanda T,Furukawa T,et al.The effect of a thymidine phosphorylase inhibitoron angiogenesis and apoptosis in tumors[J].Cancer Res,1999,59(9):1911-1916.
  • 2[2]Fujiwaki R,Hata K,Iida K,et al.Immunohistochemical expression of thymidinne phosphorylase in human endometrial cancer[J].Gyne Onco,1998,68(3):247-252.
  • 3[3]Van Triest B,Pinedo HM,Blaauwgeers JL,et al.Prognostic role of thymidylate synthase, thymidine phosphorylase/platelet-derived endometrial cell growth factor, and proliferation markers in colorectal cancer[J].Clin Cancer Res,2000, 6 (3): 1063-1072.
  • 4[4]Arima J,Imazona,Takebayashi Y,et al.Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder[J].Cancer,2000,88(5):1131-1138.
  • 5[5]Fujiwaki R,Hata K,Iida K,et al.Co-expression of vascular endometrial growth factor and thymidine phosphorylase in endometrial cancer[J].Acta Obstet Gynecol Scand,1999,78(8):728-734.
  • 6[6]Hata K,Fujiwaki R,Maede Y,et al.Expression of thymidine phosphorylase in epithelial ovarian cancer:correlation with angiogenesis,apoptosis,and ultrasound-derived peak systolic velocity[J].Gynecol Oncol,2000,77(1):26-34.
  • 7[7]Fujimoto J,Ichigo S,Sakaguchi H,et al.Expression of platelet-derived endothelial cell growth factor (PD-ECGF)and its mRNA in uterine endometrial cancers[J].Cancer Letters,1998,130(1):115-120.
  • 8[8]Zhang L,Mackenzine IZ,Rees MCP,et al.Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines[J].Endocriology,1997,138(11):4921-4930.
  • 9[9]Yonenaga F,Takasaki T,Ohi Y,et al.The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer[J].Pathol Int,1998,48(11):850-856.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部